Dr. Jennifer Jager received her Ph.D. in Biology from the University of Nice-Sophia Antipolis (France) in 2009, where she studied the contribution of the MAPK ERK pathway to obesity-induced adipose tissue inflammation and insulin resistance.
She conducted her postdoctoral research in the laboratory of Dr. Mitchell Lazar at the University of Pennsylvania (USA), where she developed technologies such as Global Run-On Sequencing (GRO-seq) to study the nuclear receptor Rev-erbα and mechanisms by which it regulates gene transcription to control circadian and metabolic physiology in vivo in different tissues, including in adipose tissue. Then, she joined the team of Dr. Myriam Aouadi at the Karolinska Institutet (Sweden) to investigate the role of immune cells in metabolic tissues during obesity and the development of insulin resistance. Since 2018, she is a Principal Investigator at the Mediterranean Center for Molecular Medicine at the University of Côte d’Azur (France), in the team directed by Drs. Jean-François Tanti and Mireille Cormont. Her research focuses on the transcriptional regulation of macrophages and adipocytes metabolism and their interaction within adipose tissue during obesity.